Sumitomo Mitsui Trust Group Inc. Purchases 5,149 Shares of AMETEK, Inc. $AME

Key Points

• Sumitomo Mitsui Trust Group Inc. increased its holdings in AMETEK, Inc. by 1.0% by purchasing an additional 5,149 shares during the second quarter, bringing their total shares owned to 524,946, valued at approximately $94,994,000.
• AMETEK reported a Q2 earnings per share of $1.78, exceeding analyst estimates, with revenue of $1.78 billion, and has set guidance for Q3 2025 EPS between 1.720-1.760.
• The company announced a quarterly dividend of $0.31 per share, representing an annualized dividend yield of 0.7% and a payout ratio of 19.97%.

Sumitomo Mitsui Trust Group Inc. grew its holdings in shares of AMETEK, Inc. (NYSE:AME - Free Report) by 1.0% during the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 524,946 shares of the technology company's stock after buying an additional 5,149 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned 0.23% of AMETEK worth $94,994,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Bares Capital Management Inc. purchased a new stake in shares of AMETEK in the first quarter valued at approximately $26,000. ST Germain D J Co. Inc. raised its position in AMETEK by 628.6% during the 2nd quarter. ST Germain D J Co. Inc. now owns 153 shares of the technology company's stock valued at $28,000 after purchasing an additional 132 shares in the last quarter. Olde Wealth Management LLC purchased a new stake in shares of AMETEK in the 1st quarter worth $29,000. Annis Gardner Whiting Capital Advisors LLC increased its stake in shares of AMETEK by 57.7% during the first quarter. Annis Gardner Whiting Capital Advisors LLC now owns 194 shares of the technology company's stock valued at $33,000 after buying an additional 71 shares during the period. Finally, Zions Bancorporation National Association UT bought a new stake in shares of AMETEK in the first quarter valued at about $42,000. Institutional investors own 87.43% of the company's stock.

AMETEK Trading Down 1.2%

Shares of NYSE:AME opened at $186.96 on Friday. The business's 50-day moving average is $186.02 and its 200 day moving average is $179.50. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.63 and a quick ratio of 1.04. AMETEK, Inc. has a 1 year low of $145.02 and a 1 year high of $198.33. The firm has a market capitalization of $43.18 billion, a P/E ratio of 30.11, a P/E/G ratio of 2.69 and a beta of 1.11.

AMETEK (NYSE:AME - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The technology company reported $1.78 earnings per share for the quarter, topping analysts' consensus estimates of $1.69 by $0.09. The business had revenue of $1.78 billion for the quarter, compared to analyst estimates of $1.74 billion. AMETEK had a return on equity of 16.53% and a net margin of 20.60%.The company's revenue was up 2.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.66 earnings per share. AMETEK has set its Q3 2025 guidance at 1.720-1.760 EPS. FY 2025 guidance at 7.060-7.200 EPS. On average, research analysts predict that AMETEK, Inc. will post 7.15 earnings per share for the current fiscal year.

AMETEK Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Monday, September 15th were issued a dividend of $0.31 per share. The ex-dividend date of this dividend was Monday, September 15th. This represents a $1.24 dividend on an annualized basis and a dividend yield of 0.7%. AMETEK's payout ratio is 19.97%.

Analysts Set New Price Targets

AME has been the topic of a number of research reports. Melius downgraded shares of AMETEK from a "buy" rating to a "hold" rating and set a $192.00 target price on the stock. in a research report on Monday, July 14th. Mizuho upped their target price on AMETEK from $212.00 to $225.00 and gave the stock an "outperform" rating in a report on Friday, August 1st. Barclays initiated coverage on AMETEK in a report on Wednesday, September 10th. They issued an "equal weight" rating and a $200.00 price target on the stock. Weiss Ratings restated a "buy (b)" rating on shares of AMETEK in a research note on Friday. Finally, TD Cowen upgraded AMETEK from a "sell" rating to a "hold" rating and lifted their target price for the company from $158.00 to $180.00 in a research note on Tuesday, September 2nd. Eight investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $207.42.

About AMETEK

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.

Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.